Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine and psychological intervention for motor conversion disorder
2008-004167-19Phase 3Terminated
- Sponsor
- Pro Persona
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Dissociative neurological symptom disorder (DNSD) comparing Paroxetine plus psychological intervention with Placebo / control (2 arms). Primary endpoints: Change in intensity of conversion symptoms (VRMC), Change in number of conversion symptoms (SCID I) and 1 more. Started Sep 2008; status: terminated.
02
Drugs
paroxetine
03
Conditions
Dissociative neurological symptom disorder (DNSD)
Beyond the preview
Go deeper on 2008-004167-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004167-19.